vancomycin has been researched along with oxazolidin-2-one in 475 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (0.63) | 18.7374 |
| 1990's | 9 (1.89) | 18.2507 |
| 2000's | 219 (46.11) | 29.6817 |
| 2010's | 234 (49.26) | 24.3611 |
| 2020's | 10 (2.11) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzei, T; Mini, E; Novelli, A; Periti, P | 1 |
| Brumfitt, W; Hamilton-Miller, JM; Maple, PA | 1 |
| Barry, AL | 1 |
| Barbachyn, MR; Brickner, SJ; Ford, CW; Hamel, JC; Hutchinson, DK; Moerman, JK; Stapert, D; Wilson, DM; Yancey, RJ | 1 |
| Allison, JW; Barbachyn, MR; Brickner, SJ; Glickman, SE; Hutchinson, DK; Kilburn, JO; Schaadt, RD; Yagi, BH; Zurenko, GE | 1 |
| Kaatz, GW; Seo, SM | 1 |
| Aeschlimann, JR; Cappelletty, DM; Kaatz, GW; Moldovan, T; Rybak, MJ | 1 |
| Kruzynski, J; Noskin, GA; Peterson, LR; Siddiqui, F; Stosor, V | 1 |
| Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
| Hacek, D; Noskin, GA; Peterson, LR; Siddiqui, F; Stosor, V | 1 |
| Eliopoulos, GM; Moellering, RC; Schülin, T; Thauvin-Eliopoulos, C | 1 |
| Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
| Lundstrom, TS; Sobel, JD | 1 |
| Goldsmith, D; Gransden, W; Melzer, M | 1 |
| Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY | 1 |
| Chin, KG; Mactal-Haaf, C; McPherson, CE | 1 |
| Kite, P; Mills, K; Sugden, S; Wilcox, MH | 1 |
| Cammarata, S; Oliphant, T; Rubinstein, E; Wunderink, R | 1 |
| Batts, DH; Buchanan, LV; Dailey, CF; Dileto-Fang, CL; Ford, CW; Gibson, JK; Oramas-Shirey, MP | 2 |
| Crouch, CW; Glick, HA; Hafkin, B; Li, Z; Pinto, LA; Pleil, AM; Rittenhouse, BE; Rybak, MJ; Willke, RJ | 1 |
| DenBesten, K; Gonzales, RD; Graham, MB; Kelkar, S; Quinn, JP; Schreckenberger, PC | 1 |
| Longworth, DL | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Valli, M | 1 |
| Glick, HA; Li, JZ; Rittenhouse, BE; Willke, RJ | 2 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Atkins, JL; Dziewulski, P; Hidvegi, N; Teare, L | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Balan, D; Li, Z; Nathwani, D; Rittenhouse, B; Vinken, A; Wilike, R | 1 |
| Saxén, H; Vaara, M | 1 |
| Batts, DH; Hafkin, B; Herr, D; Hunt, JL; Lampiris, H; Stevens, DL | 1 |
| Anderegg, TR; Deshpande, LM; Jones, RN | 1 |
| Bassetti, D; Bassetti, M; Cenderello, G; Di Biagio, A; Melica, G; Rosso, R | 1 |
| García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL; Sánchez Hernández, FJ; Segovia Hernández, M; Yagüe Guirao, G | 1 |
| Abb, J | 1 |
| Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Miyazaki, Y; Murata, I; Sawai, T; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Batard, E; Boutoille, D; Bugnon, D; Caillon, J; Hamel, A; Jacqueline, C; Kergueris, MF; Perez, L; Potel, G | 1 |
| Fujikawa, T; Kobayashi, I; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Birmingham, MC; Forrest, A; Moise, PA; Schentag, JJ | 1 |
| Al-Hassawi, N; Ali, AA; Phillips, OA; Udo, EE | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Grohs, P; Gutmann, L; Kitzis, MD | 1 |
| Johnson, JR | 1 |
| Pigrau, C | 1 |
| Bugnon, D; Caillon, J; Donnio, PY; Jacqueline, C; Le Mabecque, V; Miegeville, AF; Potel, G | 1 |
| Nathwani, D | 1 |
| Li, JZ; Rittenhouse, BE; Rybak, MJ; Willke, RJ | 1 |
| Cha, R; Rybak, MJ | 1 |
| Gold, HS; Inglima, K; Pillai, SK; Press, RA; Rahim, S; Venkataraman, L | 1 |
| Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Cammarata, SK; Kollef, MH; Oliphant, TH; Wunderink, RG | 1 |
| Sunagawa, M; Ueda, Y | 1 |
| Ballesta, S; García, I; Pascual, A; Perea, EJ | 1 |
| Adler, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Kaplan, SL; Morfin, MR; Naberhuis-Stehouwer, S; Wu, E; Yogev, R | 1 |
| Chang, WN; Huang, CR; Lu, CH | 1 |
| Chiang, FY; Climo, M | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Colleran, E; Cormican, M; Curtin, J; Fleming, G; Keelehan, J | 1 |
| Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ | 1 |
| Adler, S; Azimi, PH; Beltran, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Jantausch, BA; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Adler, S; Bruss, JB; Edge-Padbury, B; Kaplan, SL; Martin, A; Morfin, MR; Naberhuis-Stehouwer, S; Patterson, LE; Yogev, R | 1 |
| Bruss, JB; Edge-Padbury, B; Kaplan, SL; Meissner, HC; Morfin, MR; Naberhuis-Stehouwer, S; Townsend, T; Wenman, W | 1 |
| Batiste, B; Bürli, R; Duan, JX; Garcia, M; Gross, M; Hoch, U; Jiang, V; Johnson, KW; Jones, P; Kaizerman, J; Moser, H; Tanaka, R | 1 |
| Bauer, TT | 1 |
| Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 2 |
| Schwartz, MD; Shaikh, ZH; Shive, DK | 1 |
| Cammarata, SK; Kuter, DJ; Le, VH; Nasraway, SA; O'Grady, N; Shorr, AF | 1 |
| Akins, RL; Cha, R; Rybak, MJ | 1 |
| Kollef, MH; Shorr, AF; Susla, GM | 1 |
| Liu, J; Meng, QG; Wang, Q | 1 |
| Serio, RN | 1 |
| Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
| McCollum, M; Parodi, S; Rhew, DC | 1 |
| Bak, N; Charles, PG; du Cros, P; Fuller, A; Grabsch, EA; Grayson, ML; Howden, BP; Hurley, J; Johnson, PD; Korman, TM; Mayall, BC; Morris, AJ; Read, K; Roberts, SA; Robson, J; Ward, PB | 1 |
| Ioanas, M; Lode, H | 1 |
| Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
| Brunati, C; Candiani, G; Cavaleri, M; Jabés, D; Riva, S; Romanó, G | 1 |
| Fritsche, TR; Jones, RN; Moet, GJ; Sader, HS | 1 |
| Elkharrat, D; Farrell, DJ; Marchese, A; Schito, GC | 1 |
| Rao, N; Santa, ER; Wagener, MM; Yu, VL; Ziran, BH | 1 |
| Young, LS | 1 |
| Rollins, G | 1 |
| Bongiorno, D; Campanile, F; Di Nucci, GD; Pistella, E; Serra, P; Stefani, S; Venditti, M | 1 |
| Buchanan, LV; Dailey, CF; Gibson, JK; Haas, JV; Pagano, PJ; Van Enk, RA | 1 |
| Weisman, LE | 1 |
| Kalil, AC; Puumala, SE; Stoner, J | 1 |
| Lin, D; Powers, JH; Ross, DB; Soreth, J | 1 |
| Hegde, SS; Judice, JK; Kaniga, K; McCullough, J; Obedencio, G; Pace, J; Reyes, N; Shaw, JP; Skinner, R; Thomas, R; Vanasse, N; Wiens, T | 1 |
| Lam, CS; Lee, HK; Leung, KT; Ng, HL; Siu, YP; Tong, MK | 1 |
| Kapadnis, PB; Lohray, BB; Lohray, VB; Pandya, P; Srivastava, BK | 1 |
| Lopez, ID | 1 |
| LaPlante, KL; Rybak, MJ | 1 |
| Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H | 1 |
| Itani, KM; Kaafarani, HM; Swanson, RN; Weigelt, J | 1 |
| El-Azizi, M; Kanchanapoom, T; Khardori, N; Rao, S | 1 |
| Fang, CT; Hsueh, PR; Liao, CH; Teng, LJ; Tseng, SP | 1 |
| Wegner, DL | 1 |
| Amod, F; Lovering, A; Moodley, I; Nadvi, S; Peer, AK; Sunderland, J; Vawda, F; Wootton, M | 1 |
| Ofer, O; Samra, Z; Shmuely, H | 1 |
| Coyle, EA; Lewis, RE; Prince, RA; Raad, II; Wiederhold, NP | 1 |
| Polk, HC; Sharpe, JN; Shively, EH | 1 |
| Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lei, CB; Lu, CH; Wu, JJ | 1 |
| Buell, JF; Gearhart, M; Hanaway, MJ; Rudich, SM; Schneider, CR; Thomas, M; Woodle, ES | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Arora, SK; Dixit, PP; Jain, S; Nair, PS; Patil, VJ; Sinha, N | 1 |
| Dryden, M; Itani, K; Knirsch, C; Lau, W; Stevens, D; Weigelt, J | 1 |
| Alvarez-Lerma, F; del Castillo, A; Grau, S; Neipp, R; Rubio-Terrés, C | 1 |
| Chiodo, F; Manfredi, R; Sabbatani, S | 1 |
| Donskey, CJ; Pultz, NJ; Stiefel, U | 1 |
| Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Kollef, M; Kunkel, MJ; Shorr, AF | 1 |
| Bal, AM; Gould, IM | 1 |
| Wilcox, MH | 1 |
| Arns, Cda C; Follador, W; Guerra, A; Machado, AR | 1 |
| Charles, PG; Grayson, ML; Howden, BP; Johnson, PD; Ward, PB | 1 |
| Ellis, MW; Lewis, JS | 1 |
| Duttagupta, S; Itani, KM; Li, JZ; Weigelt, J | 1 |
| Corne, P; Jonquet, O; Macia, JC; Marchandin, H | 1 |
| Ma, S; Xu, X; Zhang, D | 1 |
| Hartman, CS; Jaksic, B; Leonard, LB; Martinelli, G; Perez-Oteyza, J; Tack, KJ | 1 |
| Heritage, J; Sandoe, JA; West, AP; Wilcox, MH; Wysome, J | 1 |
| Bet, PM; Debets-Ossenkopp, YJ; Kruse, AJ; Peerdeman, SM | 1 |
| Kalil, AC; Puumala, S; Stoner, J | 1 |
| Edmond, MB; Major, Y; Marra, AR | 1 |
| Camus, C; Tattevin, P | 1 |
| Itani, KM; Liu, LZ; McKinnon, PS; Sorensen, SV | 1 |
| Assaly, R; Malhotra, D; Mauro, LS; Peloquin, CA; Schmude, K | 1 |
| Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C | 1 |
| Brown, KR; Edmiston, CE; Goheen, MP; Johnson, CP; Lewis, BD; Seabrook, GR; Towne, JB | 1 |
| Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
| Dobbs, TE; Hoesley, CJ; Moser, SA; Patel, M; Stamm, AM; Waites, KB | 1 |
| Daniel Mullins, C; Kuznik, A; Levine, AR; Liu, LZ; Obeidat, NA; Shaya, FT; Wong, W | 1 |
| Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
| Brookfield, KF; Chen, J; Chiappetta, G; Conaughty, JM; Eismont, FJ; Martinez, OV | 1 |
| Clark, NC; Donlan, RM; Dumas, N; Jensen, B; Kohlerschmidt, D; Limberger, RJ; McDougal, LK; Musser, KA; Patel, JB; Shin, DH; Thompson, J; Weigel, LM; Zhu, W | 1 |
| Scheinfeld, N | 1 |
| Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
| Hryniewicz, W; Rózalska, B; Rózalska, S; Sadowska, B; Walencka, E | 1 |
| Chen, YH; Dickerman, RD; Kattner, KA; Noel, J; Seibly, JM; Stevens, QE | 1 |
| Bryant, AE; Ma, Y; McIndoo, E; Salmi, DB; Stevens, DL; Wallace, RJ | 1 |
| Brauers, J; Kresken, M; Menke, A; Morrissey, I; Orland, A; Weiher, H | 1 |
| Erstad, BL; Nix, DE; Patanwala, AE | 1 |
| Boulton, AJ; Bowling, FL; Salgami, EV | 1 |
| Appelbaum, PC; Credito, K; Lin, G | 1 |
| Vanni, T | 1 |
| Hall, RG; Maclayton, DO | 1 |
| Carmeli, Y; Carter, CT; Girase, PG; Liu, LZ; McKinnon, PS | 1 |
| Chaudhury, A; Kumar, AG | 1 |
| Flynn, HW; Harper, T; Miller, D | 1 |
| Sunakawa, K | 1 |
| Marik, PE; Salerno, D; Vahid, B | 1 |
| Estes, L; Orenstein, R | 1 |
| Lyles, A | 1 |
| Bronze, MS; Greenfield, RA; Hoffman-Roberts, HL; Obritsch, MD | 1 |
| Manfredi, R | 1 |
| Ptushkin, VV | 1 |
| Chambers, HF; Hegde, SS | 1 |
| Charles, M; Chiew, YF; Johnstone, MC; Parnell, KD; Penno, EC; Thompson, KM | 1 |
| Liu, LZ; McCollum, M; Sorensen, SV | 1 |
| Campodonico, R; Colli, A; Gherli, T | 1 |
| Bugnon, D; Caillon, J; Ge, JY; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Estes, L; Orenstem, R | 1 |
| Friedrich, L; Steinkraus, G; White, R | 1 |
| Cheung, KW; Hui, M; Lee, GC; So, RK; You, JH | 1 |
| Bolton-Maggs, PH; Clarke, RW; van Saene, HK; Verma, N | 1 |
| Aikawa, N; Aoki, N; Croos-Dabrera, R; Furue, M; Ito, T; Kohno, S; Niki, Y; Odagiri, S; Sumiyama, Y; Tack, KJ; Watanabe, S; Yamaguchi, K | 1 |
| Eder, M; Graninger, W; Hirschl, AM; Lassnigg, A; Presterl, E; Reichmann, S | 1 |
| Jenkins, I | 1 |
| Acheson, R; Charalampidou, S; Connell, P; Fennell, J; Lynch, M | 1 |
| Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
| Loffler, CA; Macdougall, C | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
| Kiffer, CR; Kuti, JL; Mendes, CM; Nicolau, DP | 1 |
| Kollef, MH; Micek, ST; Skrupky, LP | 1 |
| Cosgrove, SE; Fowler, VG | 1 |
| Linden, PK | 1 |
| Drusano, GL; Graves, J; Lodise, TP; Lomaestro, B | 1 |
| Bruder, N; Dufour, H; Lefebvre, L; Metellus, P | 1 |
| Grau, S; Rubio-Terrés, C | 1 |
| De Vecchi, E; Drago, L; Nicola, L | 1 |
| Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ | 1 |
| Dahlke, J; Franke, G; Heisig, P; Horstkotte, MA; Pothmann, W; Rohde, H; Saager, B; Scherpe, S; Sobottka, I; Timmerbeil, BS | 1 |
| De Cock, E; Duttagupta, S; Resch, A; Schürmann, D; Sorensen, SV | 1 |
| Adamis, T; Baxevanos, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Koutoukas, P; Pelekanou, A; Skiadas, I; Tsaganos, T; Tzepi, I | 1 |
| Kollef, MH; Nathwani, D; Rubinstein, E | 1 |
| Ackermann, G; Gerber, M; Löffler, B; Reischl, U; Tischendorf, K; Walch, C | 1 |
| Heymann, WR; Kil, EH; Weinberg, JM | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Abazia, DT; Marcus, A; Ross, J; Sachinwalla, E; Smolarz, BG | 1 |
| Boyce, TG; Henry, NK; Huskins, WC; Joshi, AY; Saphyakhajon, P | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| Bhateja, P; Bhatnagar, PK; Fatma, T; Khan, S; Mathur, T; Pandya, M; Rattan, A; Singhal, S; Upadhyay, DJ | 1 |
| Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
| Bhattacharyya, H; Fabian, TC; Leeper, KV; May, AK; Mendelson, MH; Solomkin, JS; Somero, MS; Wunderink, RG | 1 |
| Chong, TW; Evans, HL; Hedrick, TL; McElearney, ST; Pruett, TL; Sawyer, RG; Scheld, WM; Smith, RL; Swenson, BR | 1 |
| Chu, FY; Hsueh, PR; Huang, YT; Liao, CH; Lin, TH | 1 |
| Biernasiuk, A; Juda, M; Kalasiewicz, A; Korona-Głowniak, I; Malm, A | 1 |
| Aybek, H; Baltalarli, A; Cevahir, N; Guler, A; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Teke, Z; Turgut, H; Ucak, A | 1 |
| Decker, CF; Johnson, MD | 1 |
| Calhoun, JH; Thomas, TS; Wirtz, ED; Yin, LY | 1 |
| Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
| Ceran, N; Gorur, R; Oncul, O; Sacar, M; Sacar, S; Turhan, V; Uzun, G; Yildiz, S | 1 |
| Bounthavong, M; Hsu, DI; Okamoto, MP | 1 |
| Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP | 1 |
| Abbanat, D; Bush, K; Fernandez, J; Goldschmidt, R; Hilliard, JJ; Macielag, MJ; Melton, J | 1 |
| Baker, T; De Cock, E; Duttagupta, S; Hardewig, J; Krueger, WA; Müller, E; Piecyk, A; Reisinger, E; Resch, A; Sorensen, S | 1 |
| Cho, JH; Kim, SY; Oh, CH; Park, HB; Yoo, KH | 1 |
| Appalaraju, B; Baskaran, AC; Kandhaswamy, KA; Kriushnapriya, S; Malathy, NS; Mani, K; Shamitha Begum, A | 1 |
| Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P | 1 |
| Lee, H; Norozian, F; Raszynski, A; Torbati, D; Totapally, BR; Valcourt, K | 1 |
| Jhaveri, R; Lopez Marti, MG | 1 |
| Kaiser, GM; Mathe, Z; Paul, A; Rath, PM; Saner, FH; Treckmann, J; Vernadakis, S | 1 |
| Dang, S; Davies, D; Sigal, Y | 1 |
| Cian, F; Deiana, ML; Dolzani, L; Ferrantelli, N; Lagatolla, C; Luzzati, R; Tonin, E | 1 |
| Choe, KW; Jang, HC; Jeon, JH; Kim, CJ; Kim, EC; Kim, HB; Kim, KH; Kim, NJ; Kim, SH; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Geiss, HK; Helbig, L; Hoppe-Tichy, T; Kees, F; Kommerell, M; Schröder, K; Simank, HG; Swoboda, S | 1 |
| LaPlante, KL; Sakoulas, G | 1 |
| Bacon, AE; Couch, KA; Singh, SR; Young, DC | 1 |
| Hiramatsu, K; Ito, T; Komatsu, M; Tajima, Y; Yamashiro, Y | 1 |
| Bilal, M; Cleveland, KO; Gelfand, MS | 1 |
| Agharazii, M; Desmeules, S; Riopel, J; Savard, S | 1 |
| Batard, E; Biek, D; Caillon, J; Ge, Y; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Carson, RT; Friedman, M; Marton, JP; Menzin, J; Meyers, JL; Rothermel, CD | 1 |
| Niederman, MS | 1 |
| Bonafede, M; Evans, A; Ferro, S; Harrington, S; Lodise, TP; Lubanski, P; Patel, N; Stellrecht, K | 1 |
| Schlaudecker, JD | 1 |
| Dodds, TJ; Hawke, CI | 1 |
| Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
| Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P | 1 |
| Fily, F; Tattevin, P; Uhel, F | 1 |
| Chambers, HF; Deshpande, LM; Diep, BA; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Bounthavong, M; Hsu, DI | 2 |
| Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
| Stein, GE; Wells, EM | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Boyeras Navarro, ID; Luna, CM | 1 |
| Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Morales, G; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Dicuonzo, G; Gherardi, G; Ghezzi, MC; Lorino, G; Raponi, G | 1 |
| Baruch, AM; Bhattacharyya, H; Dryden, MS; Itani, KM; Kunkel, MJ; Weigelt, JA | 1 |
| Bonet, A; de Batlle, J; de la Torre, M; Motjé, M; Piñeiro, L; Sirvent, JM | 1 |
| Basak, S; Mallick, SK | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
| Bloem, RM; Buma, P; Mathijssen, NM; Petit, PL; Pilot, P; Schreurs, BW | 1 |
| Hennenfent, J; Lambert, BL; McBride, MV; Rodvold, KA; Schiff, G; Schumock, GT; Trese, AM; Tverdek, F; Yang, Y | 1 |
| Amador, G; Batard, E; Biek, D; Caillon, J; Ge, Y; Hamel, A; Jacqueline, C; Le Mabecque, V; Miègeville, AF; Potel, G | 1 |
| Cohen, MB; Govindaraj, S; Hekiert, AM; Montone, KT; Palmer, JN | 1 |
| Burillo, A; Gil, Y; Gómez-Garcés, JL; López-Fabal, F | 1 |
| Bandettini, R; Castagnola, E; Caviglia, I; Lorenzi, I; Macrina, G; Tacchella, A | 1 |
| Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C | 1 |
| Hogan, P; Huang, DB; Reisman, A | 1 |
| Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
| Caffrey, AR; LaPlante, KL; Quilliam, BJ | 1 |
| Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 2 |
| Abe, Y; Irie, T; Ito, M; Iwasaki, N; Kato, T; Komatsu, M; Minami, A; Sugawara, M; Takahata, M; Takekuma, Y | 1 |
| Barsić, B; Bukovski-Simonoski, S; Pangercić, A | 1 |
| Daurel, C; Leclercq, R | 1 |
| Adali, F; Asan, A; Baltalarli, A; Cevahir, N; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Susam, I; Teke, Z; Turgut, H; Yaylali, YT | 1 |
| Hewett, ML | 1 |
| Baek, SY; Chae, SE; Cho, YL; Jeong, JW; Jung, SJ; Kim, YZ; Kwak, JH; Lee, HH; Lee, HS; Park, TK; Woo, SH | 1 |
| Sakai, C; Soda, H | 1 |
| Beisser, PS; Croes, S; Deurenberg, RH; Neef, C; Stobberingh, EE; Terporten, PH | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R | 1 |
| Levy, F; Peterson, SM; Reynolds, SA; Sarubbi, FA; Shams, W; Walker, ES | 1 |
| Medico, CJ; Walsh, P | 1 |
| Ang, JY; Deville, JG; Equils, O; Huang, DB | 1 |
| Bookstaver, PB; Hashem, MG; Iqbal, R; James, CL; Le, J; Rudisill, CN; Sakoulas, G | 1 |
| Huang, DB; Itani, KM; Joseph, W; Lipsky, BA; Myers, DE; Paap, CM; Reisman, A; Weigelt, JA | 1 |
| Burkhardt, O; Pletz, MW; Welte, T | 1 |
| Derendorf, H; Estes, KS | 1 |
| Dryden, M; Eckmann, C | 1 |
| Euba, G; Karau, MJ; Mandrekar, JN; Patel, R; Rouse, MS; Schmidt, SM; Steckelberg, JM; Vergidis, P | 1 |
| Chen, Q; Huang, P; Huang, YL; Lin, ZQ | 1 |
| Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
| Álvarez Lerma, F; García Simón, M; González Pérez, MI; Rodriguez Colomo, O; Sirvent, JM | 1 |
| Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
| Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
| Barman, TK; Bhatnagar, PK; Das, B; Kalia, V; Kumar, GR; Kumar, M; Mathur, T; Raj, VS; Singhal, S; Upadhyay, DJ | 1 |
| Hassan, A; Kaleem, F; Khalid, A; Omair, M; Usman, J | 1 |
| Cercenado, E | 1 |
| Grigoryan, IV; Leonard, SN; Szeto, YG; Zolotarev, M | 1 |
| Gould, IM | 1 |
| Chang, SC; Chen, YC; Kao, TM; Wang, JT; Weng, CM | 1 |
| Akinnusi, ME; El-Solh, AA; Gao, W; Hattemer, A | 1 |
| Chen, CC; Chiang, SR; Chuang, YC; Ko, WC; Tang, HJ; Yu, WL | 1 |
| Gray, JW; Patel, M | 1 |
| Lemonovich, TL; Watkins, RR | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Karabekos, D; Karvouniaris, M; Makris, D; Zakynthinos, E | 1 |
| Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
| Cobos, N; Fernandez, J; Martínez, JA; Mensa, J; Mohamad, AM; Morata, L; Soriano, A; Sterzik, H | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Kalil, AC | 1 |
| Geiss, HK; Helbig, L; Lorenz, H; Schroeder, K; Simank, HG; Swoboda, S | 1 |
| Durant, L; Escaich, S; Gerusz, V; Maher, K; Moreau, F; Morrissey, I; Oxoby, M; Prouvensier, L; Saccomani, M; Soulama-Mouze, C; Vongsouthi, V | 1 |
| Cleveland, KO; Gelfand, MS; Twilla, JD; Usery, JB | 1 |
| Cleveland, KO; Gelfand, MS; Holloway, K; King, ST; Koeth, L; Usery, JB | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Agusti, C; de la Bellacasa, JP; Esperatti, M; Filella, X; Guerrero, L; Li Bassi, G; Liapikou, M; Luque, N; Marco, F; Martinez-Olondris, P; Quera, MA; Rigol, M; Soy, D; Torres, A | 1 |
| Açıkgöz, ZC; Celikbilek, N; Güner, HR; Gürelik, FC; Güvenman, S; Ozdem, B | 1 |
| Sancak, B | 1 |
| Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P | 1 |
| Aligholi, M; Asadollahi, P; Emaneini, M; Eslampour, MA; Jabalameli, F; Khoramian, B; Shahsavan, S; Taherikalani, M | 1 |
| Lang, S; Smith, A; Teles, C | 1 |
| Kelesidis, T | 1 |
| Badiou, C; Couet, W; Lina, G; Pantrangi, M; Pichereau, S; Rose, WE; Shukla, SK | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Mikamo, H; Yamagishi, Y | 1 |
| Iatrou, C; Kouloubinis, A; Makriniotou, I; Revela, I; Samonis, G; Smirloglou, D; Sofroniadou, S; Zerbala, S | 1 |
| Broyles, JE; Finch, CK; Gelfand, MS; Hudson, JQ; Twilla, JD; Usery, JB | 1 |
| Cesur, S; Demiröz, AP; Irmak, H; Karakoç, E; Kınıklı, S; Pelitli, TS | 1 |
| Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
| Pääkkönen, M; Peltola, H | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Dihmess, A; Li, HK; Lodise, TP; Patel, N; Rivera, A; Smith, R; Tristani, L; VanDeWall, H; Woo, B | 1 |
| Kollef, MH | 1 |
| Crandon, JL; Hagihara, M; Keel, RA; Nicolau, DP; Tessier, PR | 1 |
| Betriu, C; Canut, A; Gascón, AR; Isla, A | 1 |
| Ashraf, W; Bayston, R; Ullas, G | 1 |
| Bosch, A; Calvo, M; Esperatti, M; Fernández-Barat, L; Ferrer, M; Gabarrús, A; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Torres, A; Vila, J | 1 |
| Arias, CA; Hall, AD; Murray, BE; Rybak, MJ; Steed, ME | 1 |
| Cordero Carrasco, JL; Fajardo Olivares, M; Gaona Álvarez, C; Hernández Rastrollo, R; Hidalgo Orozco, R; Martínez Tallo, E; Rodríguez Garrido, S; Sánchez Silos, RM | 1 |
| Álvarez-Lerma, F; Gimeno Costa, R; Gracia Arnillas, MP; Insausti Ordeñana, J; López Pueyo, MJ; Olaechea Astigarraga, P; Palomar Martínez, M; Seijas Betolaza, I | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; Ibáñez-Martínez, J; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pichardo, C | 1 |
| Coakley, C; Grace, Y; Poulakos, MN | 1 |
| Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
| Franzblau, SG; Ji, C; Lin, W; Miller, MJ; Möllmann, U; Moraski, GC; Pucci, MJ; Thanassi, JA | 1 |
| Duane, TM; Huang, DB; Puzniak, LA; Weigelt, JA | 1 |
| Inaba, H; Miyamoto, K; Okajima, M; Sai, Y; Shiraishi, Y | 1 |
| Chang, CM; Chou, CH; Ko, WC; Lee, CC; Lee, HC; Lee, NY | 1 |
| Bonilla, H; Fakih, MG; Fugelli, A; Johnson, L; Olsen, WM; Pawlak, J; Saravolatz, LD | 1 |
| Agustí, C; Cortadellas, N; Esperatti, M; Fernández-Barat, L; Ferrer, M; Guerrero, L; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Saucedo, LM; Sierra, JM; Soy, D; Torres, A; Vila, J | 1 |
| Acar, N; Bourcier, T; Gaucher, D; Jehl, F; Lefèvre, S; Marcellin, L; Prévost, G; Saleh, M; Subilia, A | 1 |
| Brown, T; Bulitta, JB; Forrest, A; Hanna, D; Holden, PN; Kelchlin, PA; Peloquin, CA; Skerlos, L; Tsuji, BT | 1 |
| Boucher, BA; Christopher Wood, G; Croce, MA; Fabian, TC; Hamilton, LA; Magnotti, LJ; Martin, JB; Swanson, JM | 1 |
| Niki, Y | 1 |
| Clark, NM; Grim, SA; Janda, WM; Layden, JE; Lee, TA; Santayana, EM | 1 |
| Baruch, AM; Bhattacharyya, H; Biswas, P; Itani, KM; Reisman, A | 1 |
| Del Prado, G; Doadrio, JC; Esteban, J; Gómez-Barrena, E; Manzano, M; Molina-Manso, D; Ortiz-Pérez, A; Vallet-Regí, M | 1 |
| Anderson, DJ; Devine, ST; Ford, KD; Kaye, KS | 1 |
| Clark, CR; Karau, MJ; Patel, R; Rajagopalan, G; Schmidt, SM; Tilahun, AY | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Alaniz, C; Pogue, JM | 1 |
| Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
| Deshpande, LM; Farrell, DJ; Jones, RN; Mendes, RE; Shopsin, B; Smyth, DS | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Buke, C; Calik, S; Sipahi, OR; Turhan, T; Yurtseven, T | 1 |
| Arnold, FW; Griffin, AT; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
| Kang, H; Kim, H; Nam, SJ; Rho, BJ; Wang, W | 1 |
| Das, D; Garcia, LG; Lemaire, S; Mélard, A; Rozenberg, R; Tulkens, PM; Van Bambeke, F | 1 |
| Bommarito, S; Chaudhry, A; Farhat, M; Hayakawa, K; Ho, K; Jagadeesh, KK; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Moshos, JA; Mroue, R; Nanjireddy, P; Obeid, T; Parveen, S; Pogue, JM; Rybak, MJ; Singla, M; Sunkara, B; Vadlamudi, G | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Bathina, P; Bheemreddy, S; Campbell, ML; Chugh, N; Hayakawa, K; Kaye, KS; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Pulluru, H; Rybak, MJ; Sunkara, B; Wilson, MN | 1 |
| Church, TJ; Segarra-Newnham, M | 1 |
| Descourouez, JL; Jorgenson, MR; Rose, WE; Wergin, JE | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Campbell, RA; Franks, Z; Holloway, JT; Kraemer, BF; Marvin, JE; Rondina, MT; Vieira de Abreu, A; Weyrich, AS; Zimmerman, GA | 1 |
| Allen, J; Brevard, SB; Frotan, MA; Gonzalez, RP; Rostas, J; Simmons, JD | 1 |
| Herwald, H | 1 |
| Fusco, DN; He, Y; Liu, X; Papanicolaou, GA; White, JR; Xiao, K | 1 |
| Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
| Chen, C; Chen, S; Fu, J; Ye, X | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Afasizheva, A; Badiou, C; Chambers, HF; Diep, BA; Kajikawa, O; Le, HN; Lina, G; Matute-Bello, G; Sellman, B; Tkaczyk, C | 1 |
| An, MM; Jiang, YY; Shen, H; Xu, GT; Zhang, JD | 1 |
| Ahn, SH; Fowler, VG; Sharma-Kuinkel, BK; Yan, Q; Zhang, Y | 1 |
| Jiang, H; Tang, RN; Wang, J | 1 |
| Micota, B; Paszkiewicz, M; Różalska, B; Różalski, MI; Sadowska, B; Więckowska-Szakiel, M | 1 |
| Flamm, RK; Jones, RN; Sader, HS | 1 |
| Erdurmus, M; Hakyemez, IN; Kucukbayrak, A; Mengeloglu, FZ; Ozyalvacli, G; Simavli, H; Tas, T | 1 |
| Arda, B; Aydemir, S; Bardak-Ozcem, S; Dalbasti, T; Pullukcu, H; Ruksen, M; Sipahi, H; Sipahi, OR; Turhan, T; Ulusoy, S; Yurtseven, T; Zileli, M | 1 |
| Aguilar, L; Alou, L; Cafini, F; Gimenez, MJ; Gomez-Lus, ML; Gonzalez, N; Prieto, J; Sevillano, D | 1 |
| Barajas, G; Malczynski, M; McLaughlin, M; Qi, C; Radetski, J; Scheetz, MH; Zembower, T | 1 |
| Beaume, M; Francois, P; Harrison, PF; Hernandez, D; Howden, BP; Schrenzel, J; Seemann, T; Stinear, TP | 1 |
| Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
| Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
| Chen, X; Dong, BR; Liu, GJ; Wu, T; Yang, M; Yue, J | 1 |
| Biswas, P; Capitano, B; Duane, TM; Joshi, M; Puzniak, LA | 1 |
| Gardner, J; Toledo-Pereyra, LH; Zaffiri, L | 1 |
| Feng, NN; He, LX; Li, HY; Song, YL; Wang, Q; Xie, HM; Zhou, CM | 1 |
| Davidson, BR; Gurusamy, KS; Koti, R; Toon, CD; Wilson, P | 1 |
| Cunha, A; Rocha, JL | 1 |
| Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
| Mansouri, S; Sadeghi, J | 1 |
| Lazariu, V; Lodise, TP; McNutt, LA; Patel, N; Rivera, A; Tristani, L; Vandewall, H | 1 |
| Amoroso, L; Bandettini, R; Banov, L; Barabino, P; Castagnola, E; Ciucci, A; Faraci, M; Loy, A; Moscatelli, A; Risso, F | 1 |
| Bétrisey, B; Furustrand Tafin, U; Jeddari, S; Maiolo, EM; Oliva, A; Trampuz, A | 1 |
| Bo, J; Huang, WR; Jing, Y; Li, HH; Wang, QS; Wang, SH; Zhao, Y | 1 |
| Chavanet, P | 1 |
| Hagioka, S; Hagiya, H; Otsuka, F | 1 |
| Balli, EP; Miyakis, S; Venetis, CA | 1 |
| Chen, X; Enderlin, M; Fournier, E; Hubschwerlen, C; Keck, W; Kelly, CP; Klenk, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S; Seiler, P | 1 |
| Bruyère, T; Caspers, P; Keck, W; Knezevic, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S | 1 |
| Kett, DH; Puttagunta, S; Quartin, AA; Scerpella, EG | 1 |
| Cheng, L; Cheng, LI; Damschroder, M; Datta, V; Du, Q; Feng, H; Hilliard, JJ; Hua, L; Keller, A; O'Day, T; Ren, S; Robbie, G; Sellman, BR; Shi, Y; Stover, CK; Suzich, J; Tkaczyk, C; Yu, X; Zinsou, R | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Biswas, P; Capitano, B; Lodise, TP; Puzniak, LA | 1 |
| d'Azevedo, PA; Reiter, KC; Sant'Anna, FH | 1 |
| Collins, CD; McComb, MN | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Brunati, C; Candiani, G; Donadio, S; Gaspari, E; Jabes, D; Maffioli, S; Riva, S; Romanó, G; Rossi, R; Simone, M | 1 |
| Caffrey, AR; Laplante, KL; Morrill, HJ; Puzniak, LA | 1 |
| Abduljaleel, SA; Atshan, SS; Awang Hamat, R; Ghaznavi-Rad, E; Jeevajothi Nathan, J; Karunanidhi, A; Lung, LT; Mateg Ali, A; Nor Shamsudin, M; Pei Pei, C; Sekawi, Z | 1 |
| Fujii, S; Kunimoto, Y; Makino, S; Miyamoto, A; Nakata, H; Noda, N; Sakurai, K; Takahashi, S | 1 |
| Coelho, FL; de Matos, PD; Dos Santos, KR; Ferreira, DC; Freitas, AI; Iorio, NL; Pereira, MO; Sedaca, S; Sousa, C; Toledo, VC | 1 |
| Muscedere, J | 1 |
| Fröding, I; Håkanson, A; Ottosson, C | 1 |
| Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T | 1 |
| da Silva, LP; de Almeida, LM; de Araújo, MR; de Brito, AC; Gales, AC; Ito, LC; Iwasaki, MF; Lincopan, N; Mamizuka, EM; Pavez, M; Rocha, D; Sacramento, AG; Sampaio, JL | 1 |
| Altare, F; Asehnoune, K; Broquet, A; Caillon, J; Davieau, M; Jacqueline, C; Potel, G; Roquilly, A | 1 |
| Campanile, F; Cavallo, R; Corcione, S; De Rosa, FG; Di Perri, G; Fossati, L; Motta, I; Ranieri, VM; Stefani, S | 1 |
| Carroll, KC; Dam, LM; Eisinger, SW; Neoh, KM; Riedel, S; Tekle, T | 1 |
| Campana, EH; Carvalhaes, CG; Gales, AC; Machado, AM; Nonato, B | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Coyle, E; Nesher, L; Prince, RA; Rolston, K; Shelburne, S; Wang, W | 1 |
| Boucher, HW; Das, AF; Dunne, MW; Puttagunta, S; Talbot, GH; Wilcox, M | 1 |
| Arhin, FF; Moeck, G; Sarmiento, I | 1 |
| File, TM; Ford, KD; Kelley, R; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Stein, GE; Welch, V; Wiemken, TL; Zervos, MJ | 1 |
| Chambers, R; Charbonneau, C; Eckmann, C; Haider, S; Hajek, P; Lawson, W; Li, JZ; Macahilig, C; Nathwani, D; Simoneau, D; Solem, CT; Stephens, JM | 1 |
| Cabellos, C; Force, E; Garrigós, C; Pachón-Ibañez, ME; Taberner, F | 1 |
| Bizzini, A; Hartke, A; Rio-Marques, L | 1 |
| Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ | 1 |
| Charbonneau, C; Chastre, J; Gao, X; Nathwani, D; Niederman, M; Patel, DA; Shorr, AF; Simor, A; Stephens, JM | 1 |
| Arimoto, H; Kamimori, H; Kinouchi, H; Kitagawa, H; Maki, H; Nishiguchi, K; Oka, M | 1 |
| Hohenforst-Schmidt, W; Huang, H; Kioumis, I; Lampaki, S; Li, Q; Organtzis, J; Pataka, A; Petridis, D; Pezirkianidis, N; Pitsiou, G; Porpodis, K; Spyratos, D; Yarmus, L; Zarogoulidis, K; Zarogoulidis, P | 1 |
| Adam, R; Michels, G; Müller, C; Nosseir, NS; Pfister, R; Wiesen, MH | 1 |
| Holmes, NE; Howden, BP | 1 |
| Bai, Y; Di, X; Liu, B; Liu, Y; Wang, J; Wang, R; Zhang, X | 1 |
| Cleveland, KO; Finch, CK; Gelfand, MS; Self, TH; Usery, JB; Vo, NH | 1 |
| Arnold, C; Fowler, VG; Holland, TL | 1 |
| Stahlmann, R | 1 |
| Coato, P; Cojutti, P; Pea, F; Rigoli, R; Sartor, A; Scarparo, C | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Gallagher, JC; Patel, R | 1 |
| Dong, W; Dong, Y; He, H; Wang, T; Wang, Y; Xie, J; Xing, J; Zheng, X; Zou, Y | 1 |
| Steiner, M | 1 |
| Atmaca, S; Dal, T; Dayan, S; Deveci, Ö; Özcan, N; Tekin, A; Tekin, R | 1 |
| Chang, SC; Chuang, YC; Lin, HY; Wang, JT | 1 |
| Fusco, NM; Prescott, WA; Toussaint, KA | 1 |
| Peyrani, P; Ramirez, J | 1 |
| Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Hoeft, A; Jahnert, S; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C | 1 |
| Chen, Y; Jing, CM; Wang, C; Xie, W | 1 |
| Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M | 1 |
| Jeon, YL; Kang, SY; Kim, MH; Lee, WI; Yang, HS | 1 |
| Best, E; Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Hecht, DW; Kracker, H; Locher, HH; Louie, T; Nord, CE; Osmolski, JR; Sambol, S; Talbot, GH; Wilcox, M | 1 |
| Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
| Albini, TA; Flynn, HW; Kuriyan, AE; Miller, D; Pathengay, A; Relhan, N | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Fang, J; Li, JJ; Shang, EN; Tang, L; Wang, SN; Weng, XH | 1 |
| Kaysin, A; Viera, AJ | 1 |
| Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
| Dupont, J; Prat, D; Sztrymf, B | 1 |
| Bolz, DD; Bond, L; Bryant, AE; Davidson, SM; Dockstader, P; Hobdey, SE; Katahira, EJ; Stevens, DL | 1 |
| Abdul Momin, HF; Betts, JW; Phee, LM; Wareham, DW | 1 |
| Prince, RA; Raad, II; Reitzel, R; Rolston, KVI; Shelburne, SA; Vargas-Cruz, N | 1 |
| Avaca-Crusca, JS; Camargo, ILBDC; Dabul, ANG; Okado, JB; Oliveira, AL | 1 |
| Birchall, S; Corbett, D; Locher, HH; Skinner, K; Thommes, P | 1 |
| Abdelraouf, K; Kidd, JM; Nicolau, DP | 1 |
| Albert, E; Ali, N; Muhammad, A; Rawish, F; Sabih, R; Simcha, W | 1 |
| Abreu, MA; Carvalho, R; Couto de Carvalho, A; Reis, E; Santos, T | 1 |
| Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Shibata, Y; Yamagishi, Y | 1 |
| Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
| Aspinall, SL; Buehrle, DJ; Clancy, CJ; Smith, KJ; Vu, M | 1 |
| Arias, CA; Axell-House, D; Khan, A; Miller, WR; Munita, JM | 1 |
| Carvalhaes, CG; Castanheira, M; DeVries, S; Mendes, RE; Rhomberg, PR; Sader, HS | 1 |
| Ito, Y; Kanda, N; Kano, Y; Kobuchi, S; Okumi, T; Sakaeda, T; Tachi, H | 1 |
| Bhando, T; Borrillo, L; Brown, ED; Coombes, BK; Farha, MA; Fragis, M; Jardine, E; Johnson, JW; Klobucar, K; MacKinnon, MR; Magolan, J; Nkonge, B; Tsai, CN | 1 |
| Li, H; Li, Z; Lyu, C; Shen, J; Wang, X; Zhang, L | 1 |
76 review(s) available for vancomycin and oxazolidin-2-one
| Article | Year |
|---|---|
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin | 2000 |
Use of anti-infective agents during lactation: Part 1--Beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Therapy, Combination; Female; Humans; Lactation; Linezolid; Milk, Human; Mothers; Oxazolidinones; Vancomycin; Virginiamycin | 2000 |
Microbial drug resistance and the roles of the new antibiotics.
Topics: Acetamides; Anti-Infective Agents; Atovaquone; Aza Compounds; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Moxifloxacin; Naphthoquinones; Oxazolidinones; Proguanil; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance; Virginiamycin | 2001 |
[New antibacterial agents].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin | 1999 |
Gram-positive bacterial resistance. A challenge for the next millennium.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin | 2002 |
[Oxazolidinones and glycopeptides].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Cell Wall; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Histamine Release; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptidoglycan; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Vancomycin | 2003 |
Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin | 2003 |
Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient.
Topics: Acetamides; Anti-Infective Agents; Child; Child, Preschool; Coagulase; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Linezolid; Oxazolidinones; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus; Treatment Outcome; Vancomycin | 2004 |
Alternatives for MRSA treatment in the pediatric patient.
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review.
Topics: Acetamides; Anti-Bacterial Agents; Arthritis, Infectious; Drug Therapy, Combination; HIV Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Teicoplanin; Vancomycin | 2005 |
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Linezolid; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oxazolidinones; Randomized Controlled Trials as Topic; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2005 |
Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
Topics: Acetamides; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Bacterial; Glycopeptides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vaccination; Vaccines, DNA; Vancomycin; Vancomycin Resistance | 2005 |
Update on linezolid: the first oxazolidinone antibiotic.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin | 2005 |
Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; MEDLINE; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Drug Resistance, Microbial; Glycopeptides; Humans; Linezolid; Molecular Structure; Oxazolidinones; Peptides, Cyclic; Vancomycin | 2007 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Daptomycin; Endocarditis; Equipment Contamination; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2007 |
Optimizing therapy for vancomycin-resistant enterococci (VRE).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2007 |
Pharmacoeconomics of linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Costs and Cost Analysis; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Models, Econometric; Oxazolidinones; Quality of Life; Staphylococcus aureus; Teicoplanin; Vancomycin | 2008 |
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management.
Topics: Acetamides; Algorithms; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
Topics: Acetamides; Cost-Benefit Analysis; Decision Support Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Treatment options for nosocomial pneumonia due to MRSA.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2009 |
Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2010 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Management of methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Incidence; Infusions, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
[Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2010 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
[Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Vancomycin | 2010 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Management of antibiotic-resistant infection in the newborn.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Nosocomial MRSA pneumonia: data from recent clinical trials.
Topics: Acetamides; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; DNA, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vancomycin | 2011 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
Simplifying the treatment of acute bacterial bone and joint infections in children.
Topics: Acetamides; Acute Disease; Anti-Bacterial Agents; Arthritis, Infectious; Bone and Bones; C-Reactive Protein; Child; Child, Preschool; Clindamycin; Drug Administration Schedule; Finland; Humans; Joints; Kingella kingae; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Neisseriaceae Infections; Osteomyelitis; Oxazolidinones; Prospective Studies; Randomized Controlled Trials as Topic; Staphylococcal Infections; Vancomycin | 2011 |
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Female; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Vascular Diseases | 2012 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2012 |
The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections.
Topics: Acetamides; Anti-Bacterial Agents; Glycopeptides; Humans; Linezolid; Odds Ratio; Oxazolidinones; PubMed; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome; Vancomycin | 2013 |
Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney; Kidney Function Tests; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Teicoplanin; Vancomycin | 2013 |
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Oxazolidinones; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin | 2013 |
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Humans; Injections, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2013 |
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Combinations; Enterococcus; Humans; Linezolid; Middle Aged; Oxazolidinones; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin | 2014 |
[Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Fluoroquinolones; Guideline Adherence; Humans; Intensive Care Units; Linezolid; Metabolic Clearance Rate; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Shock, Septic; Teicoplanin; Vancomycin | 2014 |
What's new in the treatment of serious MRSA infection?
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2014 |
Clinical management of Staphylococcus aureus bacteremia: a review.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2014 |
[Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Evidence-Based Medicine; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin | 2014 |
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2014 |
Vancomycin-resistant enterococcal bacteremia pharmacotherapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Linezolid; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
Topics: Acetamides; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2015 |
What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin | 2015 |
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.
Topics: Anti-Bacterial Agents; Cephalosporins; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Tetracyclines; Vancomycin; Vancomycin Resistance; Visual Acuity | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
Cadazolid vs Vancomycin for the Treatment of Clostridioides difficile Infection: Systematic Review with Meta-analysis.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Oxazolidinones; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Vancomycin | 2021 |
Antimicrobial Susceptibility Testing for Enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Daptomycin; Enterococcus; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Tetracycline; Vancomycin | 2022 |
44 trial(s) available for vancomycin and oxazolidin-2-one
| Article | Year |
|---|---|
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Hospitalization; Humans; Linezolid; Male; Middle Aged; Monobactams; Oxazolidinones; Pneumonia; Safety; Time Factors; Treatment Outcome; Vancomycin | 2001 |
Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial.
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2001 |
Approaches to analysis of length of hospital stay related to antibiotic therapy in a randomized clinical trial: linezolid versus vancomycin for treatment of known or suspected methicillin-resistant Staphylococcus species infections.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Costs and Cost Analysis; Female; Health Care Costs; Humans; Length of Stay; Linezolid; Male; Methicillin Resistance; Middle Aged; Models, Statistical; Multicenter Studies as Topic; Oxazolidinones; Randomized Controlled Trials as Topic; Retrospective Studies; Staphylococcal Infections; Time Factors; Vancomycin | 2002 |
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Administration Routes; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin Resistance; Middle Aged; Multivariate Analysis; Oxazolidinones; Proportional Hazards Models; Staphylococcal Infections; Staphylococcus; Survival Analysis; Treatment Outcome; Vancomycin | 2002 |
Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Length of Stay; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Probability; Prognosis; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcus aureus; Treatment Outcome; Vancomycin; Wound Infection | 2003 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2003 |
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Topics: Acetamides; Bacteremia; Child; Child, Preschool; Confidence Intervals; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Probability; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2003 |
Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid for the treatment of complicated skin and skin structure infections in children.
Topics: Acetamides; Administration, Oral; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Hematologic effects of linezolid in young children.
Topics: Acetamides; Administration, Oral; Age Factors; Anemia; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Neutropenia; Oxazolidinones; Thrombocytopenia; Vancomycin | 2003 |
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Thrombocytopenia; Vancomycin | 2003 |
Linezolid eradicates MRSA better than vancomycin from surgical-site infections.
Topics: Acetamides; Adult; Aged; Analysis of Variance; Chi-Square Distribution; Female; Follow-Up Studies; Humans; International Cooperation; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Probability; Risk Assessment; Severity of Illness Index; Single-Blind Method; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Treatment Outcome; Vancomycin; Wound Healing | 2004 |
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin | 2005 |
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Humans; Internationality; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Americas; Anti-Bacterial Agents; Anti-Infective Agents; Asia; Europe; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin; Methicillin Resistance; Middle Aged; New Zealand; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Clinical Trials as Topic; Cost-Benefit Analysis; Delivery of Health Care; Drug Costs; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; Skin Diseases, Infectious; Streptococcal Infections; Treatment Outcome; Vancomycin | 2006 |
Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
Topics: Acetamides; Anti-Infective Agents; Cost-Benefit Analysis; Decision Trees; Female; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2007 |
Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.
Topics: Acetamides; Aged; Animals; Diabetic Foot; Diabetic Neuropathies; Foot Ulcer; Humans; Larva; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Patient Selection; Reproducibility of Results; Staphylococcus aureus; Vancomycin | 2007 |
Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Humans; Japan; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Incidence; Kidney; Kidney Diseases; Linezolid; Male; Middle Aged; Oxazolidinones; Vancomycin | 2008 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Prospective Studies; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Therapy, Combination; Humans; Korea; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2009 |
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
Topics: Acetamides; Americas; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Europe; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Soft Tissue Infections; South Africa; Staphylococcal Skin Infections; Vancomycin | 2010 |
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chi-Square Distribution; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Vancomycin | 2010 |
Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Chromosomes, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Skin Diseases; Staphylococcal Infections; Vancomycin | 2010 |
The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pediatrics; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Renal Dialysis; RNA, Ribosomal, 23S; Treatment Outcome; Vancomycin | 2012 |
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; DNA, Bacterial; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Staphylococcal Protein A; United States; Vancomycin | 2012 |
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Oxazolidinones; Prospective Studies; Staphylococcal Skin Infections; Vancomycin | 2013 |
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Kidney Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cross Infection; Demography; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Vancomycin | 2013 |
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysis.
Topics: Acetamides; Aged; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Skin; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2014 |
Once-weekly dalbavancin versus daily conventional therapy for skin infection.
Topics: Acetamides; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Teicoplanin; Vancomycin; Young Adult | 2014 |
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Vancomycin | 2014 |
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin | 2015 |
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Ribotyping; Vancomycin; Young Adult | 2016 |
355 other study(ies) available for vancomycin and oxazolidin-2-one
| Article | Year |
|---|---|
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Glycopeptides; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1989 |
Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Depsipeptides; Disaccharides; Drug Resistance, Microbial; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Peptides, Cyclic; Staphylococcus aureus; Teicoplanin; Temperature; Vancomycin | 1989 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Injections, Intravenous; Injections, Subcutaneous; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1996 |
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
Topics: Acetamides; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1996 |
In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazoles; Oxazolidinones; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin | 1996 |
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Ente
Topics: Acetamides; Anti-Bacterial Agents; Coagulase; Enterococcus faecalis; Enterococcus faecium; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus aureus; Vancomycin | 1998 |
Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Vancomycin | 1999 |
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin | 1999 |
In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.
Topics: Acetamides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1999 |
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Topics: Abdominal Abscess; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Linezolid; Male; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vancomycin | 1999 |
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin | 2000 |
Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Renal Dialysis; Spinal Diseases; Spine; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2000 |
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin | 2000 |
In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Catheterization; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2001 |
Efficacy of linezolid in a staphylococcal endocarditis rabbit model.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Injections, Intravenous; Linezolid; Male; Oxazolidinones; Rabbits; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2001 |
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin | 2001 |
Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Aortic Valve; Colony Count, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; Kidney; Linezolid; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
Effect of linezolid in comparison with that of vancomycin on glycocalix production: in vitro study.
Topics: Acetamides; Anti-Bacterial Agents; Glycocalyx; Humans; Linezolid; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcus aureus; Vancomycin | 2002 |
In vitro bactericidal activity of daptomycin against staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2002 |
The use of linezolid in the treatment of vancomycin-resistant enterococcal septicaemia in two patients with burn injuries.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Enterococcus; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Sepsis; Vancomycin | 2002 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Utilization Review; Floxacillin; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Public; Humans; Infection Control; Infusions, Intravenous; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United Kingdom; Vancomycin | 2001 |
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Streptococcus; Time Factors; Vancomycin | 2002 |
In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; In Vitro Techniques; Ketolides; Linezolid; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin | 2002 |
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Linezolid; Male; Methicillin Resistance; Mice; Oxazolidinones; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2002 |
In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Half-Life; Infusions, Intravenous; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2002 |
The in vitro and in vivo antibacterial characterization of vancomycin and linezolid against vancomycin-susceptible and -resistant enterococci.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Enterococcus faecalis; Humans; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2002 |
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Clinical Protocols; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2002 |
Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Topics: Acetamides; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Structure-Activity Relationship; Triazoles; Vancomycin | 2003 |
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin | 2003 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Anti-Bacterial Agents; Health Care Costs; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Culture Media; Drug Combinations; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Oxazolidinones; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 2003 |
Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
Topics: Acetamides; Anti-Bacterial Agents; Cost of Illness; Health Care Costs; Hospital Costs; Humans; Length of Stay; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Drug Tolerance; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance | 2003 |
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Topics: Acetamides; Aged; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2003 |
In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
Topics: Acetamides; Actinomyces; Anti-Bacterial Agents; Bacitracin; Bacteria, Anaerobic; Clostridioides difficile; Depsipeptides; Eubacterium; Feces; In Vitro Techniques; Intestines; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Peptides, Cyclic; Peptostreptococcus; Propionibacterium; Teicoplanin; Vancomycin | 2003 |
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Topics: Abscess; Acetamides; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Dipeptidases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hexosyltransferases; Kidney; Linezolid; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxazolidinones; Penicillin-Binding Proteins; Peptidyl Transferases; Vancomycin; Vancomycin Resistance | 2003 |
Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.
Topics: Acetamides; Anti-Bacterial Agents; Blood Bactericidal Activity; Dose-Response Relationship, Drug; Enterococcus faecalis; Humans; Hydrogen Peroxide; In Vitro Techniques; Linezolid; Methicillin Resistance; Neutrophils; Oxazolidinones; Phagocytosis; Staphylococcus aureus; Superoxides; Vancomycin; Vancomycin Resistance | 2003 |
Liver abscess caused by an infected ventriculoperitoneal shunt: doubtful etiology and time for an alternative to vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Liver Abscess; Methicillin Resistance; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Ventriculoperitoneal Shunt | 2003 |
Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Aortic Valve; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kidney; Linezolid; Macrolides; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Topics: Acetamides; Animals; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Graft Rejection; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Colony Count, Microbial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Sodium Chloride; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Pharmacology of novel heteroaromatic polycycle antibacterials.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Behavior, Animal; Calibration; Cation Transport Proteins; DNA; Dogs; Ether-A-Go-Go Potassium Channels; Female; Heterocyclic Compounds; Linezolid; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; Mutagens; Neutropenia; Oxazolidinones; Peritonitis; Pneumonia, Pneumococcal; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 2003 |
Nosocomial pneumonia: therapy is just not good enough.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2003 |
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Regression Analysis; Vancomycin | 2003 |
Delayed discovery of linezolid-resistant, vancomycin-resistant Enterococcus faecium: lessons learned.
Topics: Acetamides; Aged; Aged, 80 and over; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2004 |
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Streptococcus pneumoniae; Vancomycin | 2003 |
Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
Topics: Acetamides; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Hospital Costs; Humans; Intensive Care Units; Linezolid; Male; Oxazolidinones; Pneumonia, Aspiration; Pneumonia, Staphylococcal; Quality-Adjusted Life Years; Respiration, Artificial; Respiratory Distress Syndrome; United States; Vancomycin; Ventilators, Mechanical | 2004 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
[Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship; Sulbactam; Vancomycin | 2003 |
Acute delirium associated with combined diphenhydramine and linezolid use.
Topics: Acetamides; Acute Disease; Delirium; Diphenhydramine; Drug Combinations; Drug Interactions; Duty to Warn; Hallucinations; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Oxazolidinones; Pruritus; Risperidone; Time Factors; Vancomycin | 2004 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Costs and Cost Analysis; Female; Hospitals, Veterans; Humans; Injections, Intravenous; Linezolid; Los Angeles; Male; Methicillin Resistance; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2003 |
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Linezolid in VAP by MRSA: a better choice?
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin | 2004 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |
Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Female; Glycopeptides; Granuloma; Injections, Intramuscular; Injections, Intravenous; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
Topics: Amidohydrolases; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Enzyme Inhibitors; Gram-Positive Bacteria; Mutation; Oxazolidinones; Peptides; Quality Control; Streptogramins; Vancomycin | 2004 |
Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Ketolides; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Infections; Population Surveillance; Streptococcus pneumoniae; Vancomycin | 2004 |
Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Linezolid; Male; Middle Aged; Orthopedics; Oxazolidinones; Postoperative Complications; Prospective Studies; Thrombocytopenia; Time; Vancomycin | 2004 |
Hematologic effects of linezolid versus vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Hematologic Diseases; Humans; Linezolid; Oxazolidinones; Thrombocytopenia; Vancomycin | 2004 |
Linezolid better than vancomycin in treating drug-resistant pneumonia.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.
Topics: Acetamides; Bacteremia; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Male; Meningitis, Listeria; Methicillin Resistance; Middle Aged; Oxazolidinones; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2004 |
Effects of linezolid on staphylococcal adherence versus time of treatment.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Cross Infection; Humans; In Vitro Techniques; Linezolid; Microscopy, Electron, Scanning; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Vancomycin | 2004 |
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
Topics: Acetamides; Cross Infection; Female; Follow-Up Studies; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2004 |
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Vancomycin | 2004 |
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin | 2004 |
Treatment of vancomycin-intermediate Staphylcoccus aureus endocarditis with linezolid.
Topics: Acetamides; Amikacin; Anti-Infective Agents; Aortic Valve; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecalis; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Pyridines; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2004 |
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Culture Media; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Half-Life; Kinetics; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Penicillins; Staphylococcus aureus; Vancomycin | 2004 |
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin | 2005 |
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
Topics: Acetamides; Biofilms; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Virginiamycin | 2005 |
First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Oxazolidinones; Taiwan; Vancomycin | 2005 |
No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Liability, Legal; Linezolid; Methicillin Resistance; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2005 |
Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin.
Topics: Acetamides; Aged; Cerebral Ventricles; Drug Resistance, Bacterial; Drug Therapy, Combination; Encephalitis; Humans; Linezolid; Male; Oxazolidinones; South Africa; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Pristinamycin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2005 |
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Colony Count, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2005 |
Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxacillin; Oxazolidinones; Penicillin Resistance; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2005 |
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study.
Topics: Acetamides; Female; Humans; Incidence; Intensive Care Units; Length of Stay; Linezolid; Liver Transplantation; Male; Methicillin Resistance; Oxazolidinones; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Survival Analysis; Vancomycin | 2005 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Structure-Activity Relationship; Vancomycin | 2005 |
Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain.
Topics: Acetamides; Cost Savings; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Linezolid; Male; National Health Programs; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiration, Artificial; Retrospective Studies; Spain; Survival Analysis; Treatment Outcome; Vancomycin | 2005 |
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamases; Daptomycin; Enterococcus; Female; Humans; Intestines; Klebsiella pneumoniae; Linezolid; Mice; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2005 |
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin | 2005 |
Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Staphylococcus aureus; Vancomycin | 2005 |
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Fatal Outcome; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Mitral Valve; Oxazolidinones; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2005 |
The study of enantioseparation of zolmitriptan on vancomycin-bonded chiral stationary phase.
Topics: Anti-Bacterial Agents; Chemistry; Chromatography; Chromatography, High Pressure Liquid; Ethylamines; Ions; Kinetics; Models, Chemical; Oxazolidinones; Pharmaceutical Preparations; Serotonin Receptor Agonists; Stereoisomerism; Tryptamines; Vancomycin | 2005 |
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2006 |
Successful treatment with linezolid and rifampicin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to vancomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Linezolid; Meningitis, Bacterial; Methicillin Resistance; Middle Aged; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2006 |
Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Vancomycin | 2006 |
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
Topics: Acetamides; Anti-Bacterial Agents; Fever; Humans; Linezolid; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Clearance of linezolid via continuous venovenous hemodiafiltration.
Topics: Acetamides; Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Hemofiltration; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Time Factors; Urinary Tract Infections; Vancomycin | 2006 |
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Blood Vessel Prosthesis; Ceftriaxone; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus; Vancomycin | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Topics: Academic Medical Centers; Acetamides; Adult; Aged; Aged, 80 and over; Alabama; Anti-Infective Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2006 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Female; Health Care Costs; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Staphylococcus aureus; Vancomycin | 2006 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
Topics: Acetamides; Animals; Discitis; Disease Models, Animal; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Topics: Acetamides; Aminoglycosides; Biofilms; Catheters, Indwelling; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Fluoroquinolones; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Morganella morganii; Oxazolidinones; Penicillins; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Catheterization; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Drug Therapy, Combination; Humans; Linezolid; Lysostaphin; Microbial Sensitivity Tests; Microscopy, Confocal; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Reactivation of dormant lumbar methicillin-resistant Staphylococcus aureus osteomyelitis after 12 years.
Topics: Abscess; Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Drug Therapy, Combination; Humans; Intervertebral Disc Displacement; Laminectomy; Linezolid; Lumbar Vertebrae; Male; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2007 |
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Enterotoxins; Exotoxins; Hemolysin Proteins; Leukocidins; Linezolid; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Oxazolidinones; Protein Synthesis Inhibitors; Rabbits; Staphylococcus aureus; Superantigens; Vancomycin; Virulence | 2007 |
Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
Topics: Acetamides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2007 |
Economic evaluation of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Infective Agents; Cost-Benefit Analysis; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Staphylococcus aureus; Vancomycin | 2006 |
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
Topics: Acetamides; Adult; Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Female; Humans; Injections, Intravenous; Insurance Claim Review; Linezolid; Male; Managed Care Programs; Middle Aged; Oxazolidinones; Vancomycin | 2007 |
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; India; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcus; Staphylococcus haemolyticus; Teicoplanin; Vancomycin; Virginiamycin | 2007 |
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin | 2007 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Thoracic Surgical Procedures; Treatment Failure; Treatment Outcome; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Staphylococcus aureus; Survival Rate; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Disclosure; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Peer Review, Research; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin | 2007 |
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar.
Topics: Acetamides; Acute Disease; Adult; Agar; Anti-Bacterial Agents; Bone Marrow Transplantation; Drug Resistance; Humans; Immunocompromised Host; Leukemia, Myeloid; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vancomycin | 2007 |
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in
Topics: Acetamides; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2007 |
Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Endocarditis, Bacterial; Female; Gram-Positive Bacterial Infections; Health Care Costs; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Vancomycin | 2007 |
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Ceftaroline; Cephalosporins; Chromatography, High Pressure Liquid; Colony Count, Microbial; Endocarditis, Bacterial; Immunoenzyme Techniques; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2007 |
Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
Topics: Acetamides; Administration, Oral; Algorithms; Anti-Bacterial Agents; Costs and Cost Analysis; Gram-Positive Bacterial Infections; Health Care Costs; Home Care Services; Humans; Infusions, Intravenous; Joint Prosthesis; Linezolid; Methicillin Resistance; Oxazolidinones; Prosthesis-Related Infections; Vancomycin | 2007 |
Gut overgrowth of vancomycin-resistant enterococci (VRE) results in linezolid-resistant mutation in a child with severe congenital neutropenia: a case report.
Topics: Acetamides; Anti-Bacterial Agents; Child; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Intestines; Linezolid; Mutation; Neutropenia; Oxazolidinones; Protein Synthesis Inhibitors; Stem Cell Transplantation; Streptococcal Infections; Vancomycin; Vancomycin Resistance | 2007 |
Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Prosthesis-Related Infections; Streptococcal Infections; Tigecycline; Treatment Outcome; Vancomycin; Viridans Streptococci | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
Topics: Acetamides; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Therapy, Combination; Football; Humans; Linezolid; Male; Methicillin Resistance; Ophthalmic Solutions; Orbital Cellulitis; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Topics: Acetamides; Anti-Infective Agents; Area Under Curve; Brazil; Coagulase; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Teicoplanin; Vancomycin | 2008 |
Linezolid for treatment of subdural empyema due to Streptococcus: case reports.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Brain Neoplasms; Drainage; Empyema, Subdural; Facial Injuries; Female; Humans; Linezolid; Magnetic Resonance Imaging; Male; Middle Aged; Mydriasis; Neurosurgical Procedures; Oxazolidinones; Paresis; Seizures; Streptococcal Infections; Subdural Space; Vancomycin | 2009 |
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Selection, Genetic; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2008 |
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genes, Bacterial; Genes, rRNA; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Linezolid; Microbial Sensitivity Tests; Mucositis; Oxazolidinones; Pancreatitis, Acute Necrotizing; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2008 |
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Germany; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valves; Kidney; Linezolid; Liver; Lung; Male; Methicillin Resistance; Microbial Sensitivity Tests; Microbial Viability; Models, Animal; Oxazolidinones; Plasma; Rabbits; Rifampin; Spleen; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin | 2008 |
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Enterotoxins; Gene Expression Regulation, Bacterial; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Time Factors; Transcription, Genetic; Vancomycin | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Topics: Acetamides; Acetaminophen; Analgesics; Anti-Infective Agents; Cellulitis; Diphenhydramine; Drug Combinations; Famotidine; Furosemide; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Oxycodone; Pulmonary Edema; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
Topics: Acetamides; Acute Disease; Anti-Bacterial Agents; Arthritis, Infectious; Child, Preschool; Decision Trees; Humans; Infant; Kingella; Linezolid; Methicillin Resistance; Neisseriaceae Infections; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Dose-Response Relationship, Drug; Furans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Plastics; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin; Virginiamycin | 2008 |
Reduction in rates of methicillin-resistant Staphylococcus aureus infection after introduction of quarterly linezolid-vancomycin cycling in a surgical intensive care unit.
Topics: Acetamides; Anti-Bacterial Agents; Drug Administration Schedule; Enterococcus; General Surgery; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Blood; Catheters, Indwelling; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Time Factors; Treatment Failure; Vancomycin | 2008 |
Bacteriostatic or bactericidal effect of linezolid against multiresistant Streptococcus pneumoniae.
Topics: Acetamides; Anti-Bacterial Agents; Child, Preschool; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Penicillin Resistance; Phylogeny; Polymerase Chain Reaction; Streptococcus pneumoniae; Vancomycin | 2008 |
Comparison of the therapeutic efficacy of linezolid and vancomycin and correlation of serum and tissue malondialdehyde and myeloperoxidase in an experimental mediastinitis model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Linezolid; Male; Malondialdehyde; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Peroxidase; Rats; Rats, Wistar; Vancomycin | 2009 |
Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Bone Marrow; Colony Count, Microbial; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Rabbits; Random Allocation; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis.
Topics: Acetamides; Animals; Anti-Infective Agents; Combined Modality Therapy; Hyperbaric Oxygenation; Linezolid; Male; Mediastinitis; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Staphylococcal Infections; Teicoplanin; Vancomycin | 2009 |
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 2009 |
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2009 |
Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Female; Germany; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin | 2009 |
Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Heptanes; Methicillin; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Oxazolidinones; Structure-Activity Relationship; Vancomycin | 2009 |
Anti-MRSA activity of aldehyde Schiff base N-aryl thiosemicarbazones.
Topics: Acetamides; Aldehydes; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Schiff Bases; Staphylococcal Infections; Thiosemicarbazones; Vancomycin | 2009 |
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2009 |
Drug use density in critically ill children and newborns: analysis of various methodologies.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Utilization Review; Humans; Infant; Intensive Care Units, Pediatric; Intensive Care, Neonatal; Linezolid; Oxazolidinones; Retrospective Studies; Vancomycin | 2009 |
Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Bacteremia; Crohn Disease; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Treatment Outcome; Vancomycin | 2009 |
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cross Infection; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
Recurrent cellulitis in a case of Aagenaes syndrome.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cellulitis; Cholestasis, Intrahepatic; Humans; Ketorolac; Linezolid; Lower Extremity; Lymphedema; Male; Oxazolidinones; Recurrence; Syndrome; Vancomycin | 2009 |
Colonization of the tip of a thoracic catheter by Enterococcus faecalis resistant to vancomycin and linezolid.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Catheterization; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2009 |
Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
Topics: Acetamides; Animals; Anti-Infective Agents; Bone and Bones; Chromatography, High Pressure Liquid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Prosthesis-Related Infections; Rabbits; Spectrophotometry, Ultraviolet; Vancomycin | 2009 |
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Daptomycin; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2009 |
In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2009 |
Use of a sensitive chemiluminescence-based assay to evaluate the metabolic suppression activity of linezolid on methicillin-resistant Staphylococcus aureus showing reduced susceptibility to vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Luminescent Measurements; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Daptomycin; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
Topics: Acetamides; Acute Disease; Aged, 80 and over; Anti-Infective Agents; Eosinophilia; Exanthema; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Nephritis, Interstitial; Oxazolidinones; Prosthesis-Related Infections; Staphylococcal Infections; Syndrome; Vancomycin | 2009 |
In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and van
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Enterococcus faecalis; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Vancomycin; Vancomycin Resistance | 2009 |
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Utilization; Drug Utilization Review; Female; Humans; Inpatients; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2009 |
A refractory case of community-acquired pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin | 2010 |
Observational studies of salvage treatment for persistent bacteremia: beware of survivor treatment selection bias.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Vancomycin | 2009 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Spain; Staphylococcal Infections; Tetrazoles; Vancomycin | 2010 |
Analysis of methods commonly used for glycopeptide and oxazolidinone susceptibility testing in Enterococcus faecium isolates.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; DNA, Bacterial; Enterococcus faecium; Glycopeptides; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Teicoplanin; Vancomycin | 2010 |
MRSA--too many hurdles to overcome: a study from Central India.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cefoxitin; Drug Resistance, Multiple, Bacterial; Humans; Incidence; India; Inhibitory Concentration 50; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Prevalence; Staphylococcal Infections; Vancomycin | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
Impregnation of bone chips with antibiotics and storage of antibiotics at different temperatures: an in vitro study.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Transplantation; Cefazolin; Clindamycin; Dose-Response Relationship, Drug; Drug Compounding; Drug Stability; Drug Storage; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Prosthesis-Related Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temperature; Transplantation, Homologous; Vancomycin | 2010 |
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Protocols; Daptomycin; Formularies, Hospital as Topic; Guidelines as Topic; Health Care Surveys; Hospitals; Humans; Infection Control; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Organizational Policy; Oxazolidinones; Patient Isolation; Pharmacy Service, Hospital; Staphylococcal Infections; Surveys and Questionnaires; Tigecycline; Vancomycin | 2010 |
Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bone and Bones; Bone Marrow; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxazolidinones; Rabbits; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Ecthyma gangrenosum mimicking acute invasive fungal sinusitis in an immunocompromised patient.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Diagnosis, Differential; Ecthyma; Humans; Immunocompromised Host; Linezolid; Male; Mycoses; Nasal Mucosa; Ofloxacin; Oxazolidinones; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma Gangrenosum; Risk Factors; Sinusitis; Vancomycin | 2010 |
[Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2010 |
Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Chi-Square Distribution; Child; Coagulase; Daptomycin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Prospective Studies; Staphylococcus; Vancomycin | 2010 |
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin | 2010 |
Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Aged; Anti-Infective Agents; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Penetration of linezolid into rabbit intervertebral discs and surrounding tissues.
Topics: Acetamides; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Intervertebral Disc; Linezolid; Male; Oxazolidinones; Rabbits; Staphylococcus aureus; Vancomycin | 2010 |
[Vancomycin, what else?].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Child; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Infective Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Infusions, Intravenous; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 2010 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
What is MRSA?
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Gram-Positive Bacteria; Linezolid; Male; Mice; Mice, Inbred ICR; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2010 |
Severe ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus and other pathogens: report of a case successfully managed by serial surveillance cultures of endotracheal aspirates.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiratory Distress Syndrome; Staphylococcal Infections; Vancomycin | 2011 |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Penicillin Resistance; Penicillin-Binding Proteins; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Vancomycin | 2010 |
Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; Daptomycin; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
Topics: Acetamides; Aged; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Meningitis, Bacterial; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2010 |
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Diabetes Complications; Diabetic Foot; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2011 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
Topics: Acetamides; Animals; Foreign Bodies; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Vancomycin | 2011 |
Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Kidney; Linezolid; Male; Metabolic Clearance Rate; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Vancomycin | 2011 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Metronidazole; Oxazolidinones; Spores, Bacterial; Vancomycin | 2011 |
Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Hospitals, Military; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2011 |
Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin; Vancomycin Resistance | 2011 |
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Taiwan; Tigecycline; Vancomycin | 2011 |
Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia?
Topics: Acetamides; Analysis of Variance; Animals; Anti-Infective Agents; Apoptosis; Confidence Intervals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Random Allocation; Survival Rate; Treatment Outcome; Vancomycin | 2011 |
In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Topics: Acetamides; Anti-Infective Agents; Biofilms; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Stem Cells; Tigecycline; Vancomycin | 2011 |
Diagnosis and management of community-acquired pneumonia in adults.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Influenza Vaccines; Linezolid; Macrolides; Oxazolidinones; Pneumococcal Vaccines; Pneumonia, Bacterial; Practice Guidelines as Topic; Risk Factors; Treatment Outcome; United States; Vancomycin | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Comorbidity; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results?
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Risk Assessment; Treatment Outcome; Vancomycin | 2011 |
Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model.
Topics: Acetamides; Animals; Anti-Infective Agents; Biomechanical Phenomena; Female; Femur; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Prostheses and Implants; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Titanium; Vancomycin | 2012 |
The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Benzamides; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Phenyl Ethers; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2011 |
Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Interleukin-6; Interleukin-8; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiration, Artificial; Swine; Tumor Necrosis Factor-alpha; Vancomycin | 2012 |
[In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates to vancomycin, teicoplanin, linezolide and daptomycin].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2011 |
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult | 2011 |
Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Teicoplanin; Vancomycin | 2011 |
Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Endocarditis, Bacterial; Fibrinolysin; Gene Expression Regulation, Bacterial; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Penicillins; Phosphopyruvate Hydratase; Plasminogen; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Species Specificity; Streptococcal Infections; Streptococcus mitis; Streptococcus oralis; Streptococcus sanguis; Vancomycin | 2012 |
Comment on: Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Vancomycin | 2012 |
Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cell Culture Techniques; Clindamycin; Community-Acquired Infections; Enzyme-Linked Immunosorbent Assay; Exotoxins; Gene Expression Regulation, Bacterial; Humans; Leukocidins; Leukocytes, Mononuclear; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Biological; Oxazolidinones; Real-Time Polymerase Chain Reaction; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virulence Factors | 2012 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
[Case of meningitis caused by group B Streptococcus treated with high dose of meropenem].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Linezolid; Male; Meningitis, Bacterial; Meropenem; Oxazolidinones; Pulse Therapy, Drug; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Thienamycins; Treatment Outcome; Vancomycin | 2011 |
Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Enterococcus faecalis; Female; Humans; Immunocompromised Host; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Retrospective Studies; United States; Vancomycin; Vancomycin Resistance | 2012 |
[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin | 2011 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Platelets; Cohort Studies; Humans; Incidence; Linezolid; Male; Middle Aged; New York; Oxazolidinones; Thrombocytopenia; Treatment Outcome; Vancomycin | 2012 |
Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2012 |
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.
Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Survival Rate; Tetrazoles; Vancomycin | 2012 |
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
Topics: Acetamides; Anti-Bacterial Agents; Belgium; Daptomycin; Ireland; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Staphylococcal Infections; Tigecycline; United Kingdom; Vancomycin | 2012 |
Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.
Topics: Acetamides; Biofilms; Cerebrospinal Fluid Shunts; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2012 |
Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Equipment and Supplies; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Microscopy, Confocal; Oxazolidinones; Placebos; Pneumonia, Staphylococcal; Spain; Staining and Labeling; Swine; Vancomycin | 2012 |
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Acetamides; Daptomycin; Endocarditis, Bacterial; Enterococcus; Enterococcus faecalis; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin | 2012 |
[Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Topics: Acetamides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Linezolid; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus hominis; Teicoplanin; Vancomycin | 2012 |
[Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Critical Care; Critical Illness; Daptomycin; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Intensive Care Units; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2012 |
Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Female; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin | 2012 |
Probable linezolid-induced thrombocytopenia in a patient with vancomycin-resistant enterococci.
Topics: Acetamides; Aged; Anti-Infective Agents; Blood Platelets; Enterococcus; Humans; Linezolid; Male; Oxazolidinones; Platelet Count; Risk Factors; Thrombocytopenia; Vancomycin; Vancomycin Resistance; White People | 2012 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
Topics: Anti-Bacterial Agents; Cell Line; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2012 |
Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin.
Topics: Acetamides; Adsorption; Albumins; Algorithms; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Filtration; Hemodiafiltration; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Topics: Acetamides; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Incidence; Linezolid; Male; Middle Aged; Oxazolidinones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligopeptides; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2012 |
Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microscopy, Electron, Scanning; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Swine; Vancomycin | 2012 |
Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Electroretinography; Endophthalmitis; Female; Intravitreal Injections; Linezolid; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2012 |
Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Enterococcus faecalis; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Mutation; Oxazolidinones; Time Factors; Vancomycin; Vancomycin Resistance | 2012 |
Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
Topics: Acetamides; Adult; Aged; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injury Severity Score; Intensive Care Units; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiration, Artificial; Retrospective Studies; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Survival Rate; Trauma Centers; Treatment Outcome; Vancomycin; Wounds and Injuries | 2012 |
Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2012 |
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Female; Humans; Infusions, Intravenous; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Oxazolidinones; Propensity Score; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2012 |
Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: a preliminary report.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus subtilis; Biological Assay; Ceramics; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Linezolid; Micrococcaceae; Oxazolidinones; Rifampin; Silicon Dioxide; Vancomycin | 2012 |
Surgical site infection prophylaxis strategies for cardiothoracic surgery: a decision-analytic model.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefuroxime; Humans; Incidence; Linezolid; Oxazolidinones; Preoperative Care; Surgical Wound Infection; Survival Analysis; Thoracic Surgical Procedures; United States; Vancomycin | 2012 |
Linezolid is superior to vancomycin in experimental pneumonia caused by Superantigen-Producing staphylococcus aureus in HLA class II transgenic mice.
Topics: Acetamides; Animals; Linezolid; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Vancomycin | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Linezolid; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Staphylococcal Infections; Vancomycin | 2012 |
Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Comorbidity; Empirical Research; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prevalence; Proportional Hazards Models; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Antibacterial butenolides from the Korean tunicate Pseudodistoma antinboja.
Topics: 4-Butyrolactone; Acetamides; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Linezolid; Marine Biology; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazolidinones; Republic of Korea; Urochordata; Vancomycin | 2012 |
Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monocytes; Oxazolidinones; Vancomycin | 2013 |
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Case-Control Studies; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Topics: Acetamides; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cohort Studies; Cost Savings; Daptomycin; Drug Costs; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Retrospective Studies; Severity of Illness Index; Staphylococcal Infections; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Daptomycin; Drug Synergism; Enterococcus faecium; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Stents; Urinary Tract; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Blood Coagulation; Cell-Derived Microparticles; Cytokines; Drug Administration Schedule; Humans; Inflammation; Inflammation Mediators; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Monocytes; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombin; Thrombosis; Time Factors; Vancomycin | 2013 |
Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage; Female; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome; Vancomycin; Wounds, Nonpenetrating | 2013 |
Anti-inflammatory, anti-coagulant, anti-biotic?
Topics: Acetamides; Animals; Anti-Bacterial Agents; Humans; Inflammation; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombosis; Vancomycin | 2013 |
Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Coinfection; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunologic Factors; Influenza A virus; Influenza, Human; Interleukins; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Viral Load; Weight Loss | 2013 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Chemokine CCL2; Disease Models, Animal; Exotoxins; Hemolysin Proteins; Interleukin-8; Leukocidins; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Rabbits; Vancomycin | 2013 |
Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model.
Topics: Acetamides; Animals; Gene Expression Profiling; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Sepsis; Vancomycin | 2013 |
Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Thromboglobulin; Biofilms; Blood Platelets; Endocarditis, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 2013 |
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Daptomycin; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Topics: Acetamides; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Colony-Forming Units Assay; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Ophthalmic Solutions; Oxazolidinones; Rabbits; Staphylococcal Infections; Vancomycin | 2013 |
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2013 |
Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported
Topics: Acetamides; Anti-Bacterial Agents; Diabetes Mellitus; Extracellular Fluid; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Oxazolidinones; Serum; Vancomycin | 2013 |
Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.
Topics: Acetamides; Animals; Chicago; Disease Models, Animal; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Humans; Kaplan-Meier Estimate; Linezolid; Moths; Oxazolidinones; Time Factors; Vancomycin; Vancomycin Resistance | 2013 |
Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger; RNA, Small Untranslated; Sequence Analysis, RNA; Tigecycline; Transcription, Genetic; Vancomycin | 2013 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
Topics: Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; History, 20th Century; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin | 2013 |
[The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Area Under Curve; Case-Control Studies; Humans; Incidence; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Prevalence; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2013 |
Comments on new linezolid's meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2013 |
Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Child; Child, Preschool; Ciprofloxacin; Clindamycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Exotoxins; Gentamicins; Humans; Infant; Iran; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Micrococcal Nuclease; Middle Aged; Oxazolidinones; Penicillin-Binding Proteins; Phenotype; Prevalence; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2014 |
Comparative evaluation of serotonin toxicity among veterans affairs patients receiving linezolid and vancomycin.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Anticonvulsants; Antidepressive Agents; Antiemetics; Bacterial Infections; Cohort Studies; Drug Interactions; Female; Histamine Antagonists; Humans; Linezolid; Male; Middle Aged; New York; Oxazolidinones; Serotonin; Vancomycin; Veterans; Veterans Health | 2013 |
Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.
Topics: Acetamides; Anti-Bacterial Agents; Child; Coagulase; Daptomycin; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Structure-Activity Relationship; Vancomycin | 2014 |
Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
Topics: Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Calorimetry; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Foreign Bodies; Fosfomycin; Gentamicins; Gram-Positive Bacterial Infections; Guinea Pigs; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Vancomycin | 2014 |
[Retrospective analysis of the Gram-positive bacteria-infected cases in the Department of Hematology].
Topics: Acetamides; Adult; Aged; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Teicoplanin; Vancomycin | 2013 |
Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Fatal Outcome; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pulmonary Embolism; Staphylococcal Infections; Treatment Failure; Vancomycin | 2013 |
In vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Fluoroquinolones; Humans; Linezolid; Male; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Spores, Bacterial; Survival Analysis; Vancomycin | 2014 |
Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; DNA Gyrase; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Protein Biosynthesis; Recombinant Proteins; RNA; Subcellular Fractions; Transcription, Genetic; Vancomycin | 2014 |
Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Bacterial Toxins; Bronchoalveolar Lavage Fluid; Chemokines; Drug Synergism; Drug Therapy, Combination; Female; Hemolysin Proteins; Immunization, Passive; Kidney; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Survival Analysis; Vancomycin | 2014 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Gene Expression Profiling; Genes, Bacterial; Linezolid; Oxazolidinones; Real-Time Polymerase Chain Reaction; Staphylococcus epidermidis; Transcriptional Activation; Up-Regulation; Vancomycin | 2014 |
Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Decision Support Techniques; Drug Resistance, Bacterial; Enterococcus; Humans; Linezolid; Models, Economic; Monte Carlo Method; Oxazolidinones; Quality-Adjusted Life Years; Vancomycin | 2014 |
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Depsipeptides; Enterococcus; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2014 |
Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Databases, Factual; Electronic Health Records; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Propensity Score; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Vancomycin; Veterans | 2014 |
Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Daptomycin; Genetic Variation; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2013 |
Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Platelet Count; Renal Insufficiency; Retrospective Studies; Thrombocytopenia; Time Factors; Vancomycin; Young Adult | 2013 |
Antimicrobial synergism against different lineages of methicillin-resistant Staphylococcus aureus carrying SCCmec IV.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Biomass; Drug Synergism; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Rifampin; Vancomycin | 2014 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
[Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection].
Topics: Acetamides; Anti-Bacterial Agents; Humans; Knee Prosthesis; Linezolid; Male; Middle Aged; Oxazolidinones; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.
Topics: Acetamides; Brazil; Enterococcus faecalis; Enterococcus faecium; Hospitals; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci | 2014 |
Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Antigens, Ly; Bacterial Load; Cytokines; Disease Models, Animal; Endothelial Cells; Immunologic Factors; Injections, Subcutaneous; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Vancomycin | 2014 |
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Genotyping Techniques; Humans; Intensive Care Units; Italy; Linezolid; Methicillin-Resistant Staphylococcus aureus; Molecular Epidemiology; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Enterococcus; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2014 |
Comparison of M.I.C.E. and Etest with CLSI agar dilution for antimicrobial susceptibility testing against oxacillin-resistant Staphylococcus spp.
Topics: Acetamides; Agar; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Regression Analysis; Reproducibility of Results; Staphylococcus; Teicoplanin; Vancomycin | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Vancomycin | 2014 |
In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Gene Expression; Glycopeptides; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Vancomycin | 2014 |
Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.
Topics: Acetamides; Adult; Anemia; Anti-Bacterial Agents; APACHE; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2014 |
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Europe; Female; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Patient Discharge; Practice Guidelines as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Topics: Acetamides; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycopeptides; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2014 |
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin | 2014 |
Binding properties of antimicrobial agents to lipid membranes using surface plasmon resonance.
Topics: Acetamides; Anti-Infective Agents; Cell Membrane; Erythromycin; Linezolid; Membrane Lipids; Oxazolidinones; Surface Plasmon Resonance; Teicoplanin; Vancomycin | 2014 |
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.
Topics: Acetamides; Aerosols; Anti-Bacterial Agents; Daptomycin; Equipment Design; Linezolid; Nebulizers and Vaporizers; Oxazolidinones; Particle Size; Vancomycin | 2014 |
Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
Topics: Acetamides; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Oxazolidinones; Time Factors; Vancomycin | 2014 |
Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Health Care Costs; Hospitalization; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Infections; Tennessee; Treatment Outcome; Vancomycin | 2015 |
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Topics: Acetamides; Anti-Bacterial Agents; Blood; Daptomycin; Health Surveys; Humans; Italy; Linezolid; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2015 |
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin; Microbial Sensitivity Tests; Oxazolidinones; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Turkey; Vancomycin | 2014 |
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis.
Topics: Acetamides; Anti-Bacterial Agents; Cell Line; Cytokines; Daptomycin; Escherichia coli; Gene Expression Profiling; Gram-Positive Bacteria; Humans; Immunologic Factors; Linezolid; Models, Theoretical; Monocytes; Oxazolidinones; Phagocytosis; Sepsis; Toll-Like Receptors; Vancomycin | 2015 |
Minimal inhibitory concentration drift of glycopeptides and linezolid against S. Aureus at a Chinese children's center, 2009-2013.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; China; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2015 |
Optimum initial loading dose of vancomycin for pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2016 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
[Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Infant, Newborn; Linezolid; Male; Middle Aged; Neonatal Sepsis; Oxazolidinones; Platelet Count; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2016 |
Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Macrolides; Male; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2016 |
Linezolid versus vancomycin in Methicillin Resistant Staphylococcus aureus nosocomial pneumonia in the elderly.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2017 |
Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterotoxins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Vancomycin | 2017 |
Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Larva; Lepidoptera; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetrazoles; Vancomycin | 2018 |
In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Tetrazoles; Vancomycin | 2018 |
Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Topics: Bacterial Proteins; Bacteriolysis; Brazil; Cell Wall; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Polymorphism, Single Nucleotide; Staphylococcal Infections; Tetrazoles; Vancomycin | 2018 |
Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Kinetics; Microbial Sensitivity Tests; Oxazolidinones; Ribotyping; Vancomycin | 2018 |
Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Linezolid; Lung; Mice, Inbred BALB C; Neutropenia; Oxazolidinones; Pneumonia, Staphylococcal; Protein Synthesis Inhibitors; Tetrazoles; Treatment Outcome; Vancomycin | 2019 |
Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
Topics: Humans; Oxazolidinones; Retrospective Studies; Soft Tissue Infections; Vancomycin | 2020 |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin | 2021 |
Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Vancomycin | 2021 |
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Hospitals; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Tetrazoles; United States; Vancomycin | 2022 |
Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Rats; Sepsis; Tissue Distribution; Vancomycin | 2022 |
Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Erythromycin; Gram-Negative Bacteria; Linezolid; Lipid A; Novobiocin; Oxazolidinones; Rifampin; Vancomycin | 2022 |
Clinical efficacy of psychiatric nursing-based vancomycin in the treatment of Staphylococcus aureus infectious skin diseases.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Psychiatric Nursing; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2023 |